Infectious Disease (ID) Learning Unit: What the ID Clinician Needs to Know About Buprenorphine Treatment for Opioid Use Disorder | Zendy

Amanda A. Westlake | Zendy; Mark Eisenberg | Zendy

Open Access

Infectious Disease (ID) Learning Unit: What the ID Clinician Needs to Know About Buprenorphine Treatment for Opioid Use Disorder

Author(s) -

Amanda A. Westlake,

Mark Eisenberg

Publication year - 2016

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofw251

Subject(s) - buprenorphine , medicine , opioid use disorder , infectious disease (medical specialty) , opioid , intensive care medicine , context (archaeology) , waiver , disease , psychiatry , paleontology , receptor , political science , law , biology

In the context of an escalating opioid epidemic, infectious disease clinicians increasingly treat the infectious complications of injection drug use. In this learning unit, we review the history, pharmacology, and clinical use of buprenorphine as maintenance therapy for opioid use disorder, and we describe the process by which clinicians can obtain a buprenorphine waiver.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research